What is CMPX's dilution risk score?

CMPX has a latest available DilutionScore record of 38/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CMPX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CMPX?

DilutionWatch tracks 25 SEC filing types for CMPX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CMPX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CMPX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CMPX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CMPX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CMPX Dilution Risk Score: 38/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

0

📊 Float Risk

32

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 10%

💰 Capital Raise model 20%

• Active shelf registration ($400M, 93% of market cap)

🔔 Track CMPX — Get forecast alerts →

Market Data

Market Cap$428.61M

Shares Outstanding180.09M

Float122.69M

Cash$179.88M

Debt$9.79M

Short InterestN/A

Institutional Holdings

10 institutional holders · 102.14M shares

#1 Tang Capital Management, LLC 16.79M shares

#2 Orbimed Advisors LLC. 15.22M shares

#3 Suvretta Capital Management, LLC 14.31M shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest39.87M

Days to Cover17.6

% of Float32.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

4 INSIDER TRANSACTION 2026-04-29

4 INSIDER TRANSACTION 2026-02-10

4 INSIDER TRANSACTION 2026-01-12

Full SEC filing analysis available with free account →

Recent News

Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation GlobeNewswire · Jul 17

How Compass Therapeutics (CMPX) Is Moving Tovecimig Toward a Potential Biliary T Insider Monkey · Jun 17

Compass Therapeutics (CMPX) Reports Q1 2026 Net Loss of $18.3M Yahoo Finance · May 18

Factual CMPX Dilution Snapshot

Compass Therapeutics, Inc. (CMPX) has a DilutionScore of 38/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $400.0M.
Recent SEC activity tracked for CMPX: 4 on 2026-04-29; 4 on 2026-04-29; 4 on 2026-02-10.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.